IMR Press / CEOG / Volume 39 / Issue 4 / pii/1630475837045-2116439891

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Case Report
Conservative management of massive hematoperitoneum caused by ovulation in a patient with severe form of von Willebrand disease - a case report
Show Less
1 Department of Gynaecology and Obstetrics, University of Belgrade, Faculty of Medicine, Belgrade
2 Clinic of Gynaecology and Obstetrics, Clinical Center of Serbia, Belgrade (Serbia)
3 Department of Anesthesiology, Advocate Illinois Masonic Medical Center, Chicago, IL (USA)
Clin. Exp. Obstet. Gynecol. 2012, 39(4), 537–540;
Published: 10 December 2012
Abstract

Von Willebrand disease (VWD) is the most common inherited bleeding condition that involves extended or excessive bleeding, caused by the deficiency or defect of von Willebrand factor (VWF). Hematoperitoneum as a complication of gynecologic diseases represents acute condition which is usually caused by the hemorrhagic corpus luteum or a rupture of either ectopic pregnancy or a hemorrhagic ovarian cyst. The authors present a unique case of conservatively managed massive hematoperitoneum caused by ovulation in a patient with severe form of von Willebrand disease who had right adnexectomy due to hemorrhagic corpus luteum four months prior. This conservative management by blood product and factor concentrate support could be a method of choice in selected hemodynamically stable patients. Furthermore, recurrent bleeding episodes following ovulation could be prevented by suppression of ovulation using oral contraceptive pills.
Keywords
Hematoperitoneum
Ovulation
Von Willebrand disease
Conservative management
Share
Back to top